Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Return on Sales (2016 - 2025)

Historic Return on Sales for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to 1.57%.

  • ProPhase Labs' Return on Sales rose 27100.0% to 1.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.57%, marking a year-over-year decrease of 171600.0%. This contributed to the annual value of 0.56% for FY2024, which is 5500.0% down from last year.
  • As of Q3 2025, ProPhase Labs' Return on Sales stood at 1.57%, which was up 27100.0% from 1.13% recorded in Q2 2025.
  • ProPhase Labs' Return on Sales' 5-year high stood at 6.11% during Q1 2025, with a 5-year trough of 1.15% in Q3 2024.
  • Its 5-year average for Return on Sales is 0.37%, with a median of 0.03% in 2023.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -19300bps in 2024, then skyrocketed by 64300bps in 2025.
  • Over the past 5 years, ProPhase Labs' Return on Sales (Quarter) stood at 0.21% in 2021, then tumbled by -153bps to 0.11% in 2022, then skyrocketed by 1367bps to 1.42% in 2023, then plummeted by -136bps to 0.52% in 2024, then skyrocketed by 404bps to 1.57% in 2025.
  • Its Return on Sales stands at 1.57% for Q3 2025, versus 1.13% for Q2 2025 and 6.11% for Q1 2025.